TABLE 2.

MT1H expression and prognosis in HCC with different clinicopathological factors.

Clinicopathological factors	Overall survival (OS)			Progression-free survival (PFS)
	N	HR	P	N	HR	P
Sex
Female	118	1.43 (0.82–2.51)	0.21	120	1.35 (0.78–2.32)	0.28
Male	246	0.52 (0.29–0.95)	0.03	246	0.65 (0.42–0.99)	0.043
Race
White	181	0.42 (0.21–0.81)	0.008	183	0.54 (0.34–0.87)	0.01
Asian	155	0.55 (0.26–1.19)	0.12	155	0.7 (0.4–1.23)	0.21
TNM stage
1	170	0.75 (0.37–1.53)	0.42	170	1.52 (0.86–2.68)	0.15
2	83	3.03 (0.9–10.24)	0.062	84	0.64 (0.35–1.19)	0.15
3	83	0.47 (0.22–1.01)	0.048	83	0.5 (0.27–0.94)	0.029
4	4	—	—	5	—	—
1 + 2	253	1.36 (084–2.21)	0.21	254	0.72 (0.45–1.16)	0.17
3 + 4	87	0.45 (0.21–0.98)	0.038	88	0.49 (0.26–0.91)	0.022
Grade
1	55	0.29 (0.08–1.04)	0.046	55	0.23 (0.08–0.64)	0.003
2	174	3.21 (1.5–6.87)	0.0016	175	1.51 (0.95–2.41)	0.076
3	118	0.61 (0.29–1.2)	0.18	119	0.74 (0.42–1.31)	0.3
4	12	—	—	12	—	—
AJCC-T
1	180	0.74 (0.38–1.47)	0.39	180	1.51 (0.87–2.61)	0.14
2	90	2.29 (0.87–6.06)	0.085	92	0.55 (0.3–1.01)	0.05
3	78	0.42 (0.18–0.99)	0.042	78	0.45 (0.23–0.85)	0.012
4	13	—	—	13	—	—
Vascular invasion
Yes	90	3.09 (1.06–9.03)	0.03	91	0.67 (0.34–1.32)	0.24
None	203	0.55 (0.31–0.98)	0.04	204	0.63 (0.38–1.06)	0.079
Alcohol consumption
Yes	115	0.32 (0.14–0.71)	0.0033	115	0.45 (0.24–0.84)	0.01
None	202	0.74 (0.42–1.31)	0.3	204	0.77 (0.48–1.25)	0.29
Virus hepatitis
Yes	150	1.5 (0.78–2.88)	0.22	152	0.67 (0.42–1.07)	0.09
None	167	0.34 (0.17–0.66)	8e-04	167	0.62 (0.37–1.03)	0.061

^*P value <0.05 was defined as significant and marked in bold